PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsscPharmaceuticals
scPharmaceuticals(SCPH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
FuroscixFurosemide2022-10-072034
Heart failure
,
Hypertension
,
Chronic kidney failure
,
Liver cirrhosis
,
Nephrotic syndrome
,
Edema
,
Ascites
,
Pulmonary edema
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Furosemide
healthy volunteers/patients
,
heart failure
,
type 2 diabetes mellitus
Lactams
renal insufficiency
,
breast neoplasms
,
overactive urinary bladder
,
soft tissue infections
,
pelvic infection
,
urologic diseases
,
hematologic neoplasms
,
neoplasms
,
urinary tract infections
,
pyelonephritis
,
surgical wound infection
,
bacterial pneumonia
,
bacterial infections
,
diabetic foot
,
bacteremia
,
infections
,
communicable diseases
,
intraabdominal infections
,
sepsis
,
pneumonia
,
healthy volunteers/patients
,
febrile neutropenia
,
tuberculosis
,
endometritis
,
puerperal infection
,
prostatic hyperplasia
,
hypersensitivity
,
immediate hypersensitivity
,
chronic kidney failure
,
continuous ambulatory peritoneal dialysis
,
neutropenia
,
fever
,
hyperthermia
,
ventilator-associated pneumonia
,
contraception
,
critical illness
,
obesity
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use